SCHEMBL21687747

SCHEMBL21687747

N#Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2cccc(-c3ccc(-n4c5ccccc5c5cc(C#N)ccc54)cc3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGER4 P35408 2/20 0.36
PGR P06401 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
ALDH1A3 P47895 2/20 0.34
PDPK1 O15530 1/20 0.34
USP14 P54578 2/20 0.33
HDAC4 P56524 1/20 0.33
PTPN5 P54829 1/20 0.33
ADORA2A P29274 1/20 0.33
SLC22A12 Q96S37 1/20 0.32
MARK3 P27448 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687619 0.98 KDM4E (0.38) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21687631 0.97 PGR (0.37) PGRGABRA1GABRG2GABRB3GABRA5
SCHEMBL21687694 0.96 KDM4E (0.36) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21688220 0.96 ATM (0.40) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21688024 0.94 ALDH1A3 (0.37) PGRGABRA1GABRG2GABRB3GABRA5
SCHEMBL21687736 0.94 ATM (0.41) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21687697 0.93 KDM4E (0.38) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21687621 0.93 ATM (0.41) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL17463451 0.93 ATM (0.38) KDM4EATML3MBTL1PTGER4PGR
SCHEMBL21687715 0.92 KDM4E (0.37) KDM4EATML3MBTL1PTGER4GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.